Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stenson, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stenson, B.
Topic Collections
Right arrowRelated Articles
Archives of Disease in Childhood Fetal and Neonatal Edition 2003;88:F448
© 2003 Archives of Disease in Childhood Fetal and Neonatal Edition

Fantoms

Ben Stenson, Associate editor

The first 150 words of the full text of this article appear below.


FAMILY AFFAIRS
Parsons and colleagues studied the families of all nine affected infants and all 10 carrier infants identified by the newborn screening programme for cystic fibrosis after its introduction in Wales. All were in favour of screening. Implications for the wider family were the main problems highlighted. Parents were uncomfortable about not being offered the opportunity to learn the carrier status of their other children. Sharing the information with other family members was problematic, particularly where there were already family tensions. These two unresolved issues are discussed further by Super in the related leading article.
See p 448 and p 467


UPDATED META-ANALYSIS OF PROPHYLACTIC INDOMETHACIN
If you think that PDAs are for storing PDFs then you had better download this one. Prophylactic indomethacin for preterm infants reduces severe intraventricular haemorrhage and symptomatic patent ductus arteriosus (PDA), but trials with adequate follow up now show that despite this it does not change mortality, cerebral palsy, blindness, . . . [Full text of this article]


Related Articles

Cystic fibrosis newborn screening and detection of carriers
M Super
Arch. Dis. Child. Fetal Neonatal Ed. 2003 88: F448-F449. [Extract] [Full Text] [PDF]

Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis
P W Fowlie and P G Davis
Arch. Dis. Child. Fetal Neonatal Ed. 2003 88: F464-F466. [Abstract] [Full Text] [PDF]

Implications of carrier identification in newborn screening for cystic fibrosis
E P Parsons, A J Clarke, and D M Bradley
Arch. Dis. Child. Fetal Neonatal Ed. 2003 88: F467-F471. [Abstract] [Full Text] [PDF]

Neonatal weight loss in breast and formula fed infants
P D Macdonald, S R M Ross, L Grant, and D Young
Arch. Dis. Child. Fetal Neonatal Ed. 2003 88: F472-F476. [Abstract] [Full Text] [PDF]

Relapse of neonatal herpes simplex virus infection
H Kimura, M Futamura, Y Ito, Y Ando, S Hara, H Sobajima, Y Nishiyama, and T Morishima
Arch. Dis. Child. Fetal Neonatal Ed. 2003 88: F483-F486. [Abstract] [Full Text] [PDF]

Motion resistant pulse oximetry in neonates
R Sahni, A Gupta, K Ohira-Kist, and T S Rosen
Arch. Dis. Child. Fetal Neonatal Ed. 2003 88: F505-F508. [Abstract] [Full Text] [PDF]

Neonatal transfers by advanced neonatal nurse practitioners and paediatric registrars
A Leslie and T Stephenson
Arch. Dis. Child. Fetal Neonatal Ed. 2003 88: F509-F512. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health